ICML 2023 | Outcomes of patients with DLBCL following ASCT and/or CAR-T
Daniel Landsburg
• 14 Jun 2023
In this video, Daniel Landsburg, MD, University of Pennsylvania, Philadelphia, PA, explores the outcomes of an analysis which investigated a large series of patients receiving autologous stem cell transplantation (ASCT) and/or a CD19-directed CAR-T, to investigate differences in treatment failure (TF), which could inform efforts to optimize patients selection for these therapies. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
